Silva Jorge  Santos net worth and biography

Silva Santos Biography and Net Worth

Jorge Santos da Silva, is a co-Founder of MoonLake and has served as the Chief Executive Officer of MoonLake since July 2021, being also a Director of the Board. Prior to MoonLake, he was at McKinsey & Company, Inc. from September 2007 to June 2021, where he was a Senior Partner and led the Pharmaceutical & Medical Products Practice, the Biotech group and the Biosimilars group and advised international biopharmaceutical and biotechnology companies on corporate and business-unit strategy, commercial operating models, R&D, organizational design, M&A and joint ventures. Dr. Santos da Silva was a Postdoctoral Fellow at Cold Spring Harbor Laboratory, NY (USA) and holds a Ph.D. in Neuronal Cell Biology from the University of Turin (Italy) and a MSc in Molecular Biology from the University of Glasgow — Institute of Biological and Life Sciences (United Kingdom) and the European Molecular Biology Laboratory, Heidelberg (Germany). He is also a professor and Board Advisor at the School of Medicine at the Minho University in Portugal.

What is Silva Jorge Santos' net worth?

The estimated net worth of Silva Jorge Santos is at least $46.03 million as of December 8th, 2025. Santos owns 2,948,577 shares of MoonLake Immunotherapeutics stock worth more than $46,027,287 as of February 12th. This net worth estimate does not reflect any other investments that Santos may own. Additionally, Santos receives an annual salary of $1,110,000.00 as CEO at MoonLake Immunotherapeutics. Learn More about Silva Jorge Santos' net worth.

How old is Silva Jorge Santos?

Santos is currently 46 years old. There are 2 older executives and no younger executives at MoonLake Immunotherapeutics. The oldest executive at MoonLake Immunotherapeutics is Dr. Kristian Reich, Co-Founder & Chief Scientific Officer, who is 58 years old. Learn More on Silva Jorge Santos' age.

What is Silva Jorge Santos' salary?

As the CEO of MoonLake Immunotherapeutics, Santos earns $1,110,000.00 per year. The highest earning executive at MoonLake Immunotherapeutics is Dr. Kristian Reich, Co-Founder & Chief Scientific Officer, who commands a salary of $1,200,000.00 per year. Learn More on Silva Jorge Santos' salary.

How do I contact Silva Jorge Santos?

The corporate mailing address for Santos and other MoonLake Immunotherapeutics executives is , , . MoonLake Immunotherapeutics can also be reached via phone at 41-41-510-8022 and via email at [email protected]. Learn More on Silva Jorge Santos' contact information.

Has Silva Jorge Santos been buying or selling shares of MoonLake Immunotherapeutics?

Silva Jorge Santos has not been actively trading shares of MoonLake Immunotherapeutics over the course of the past ninety days. Most recently, Da Silva Jorge Santos sold 70,000 shares of the business's stock in a transaction on Tuesday, December 9th. The shares were sold at an average price of $14.49, for a transaction totalling $1,014,300.00. Following the completion of the sale, the chief executive officer now directly owns 2,878,577 shares of the company's stock, valued at $41,710,580.73. Learn More on Silva Jorge Santos' trading history.

Who are MoonLake Immunotherapeutics' active insiders?

MoonLake Immunotherapeutics' insider roster includes Matthias Bodenstedt (CFO), Kristian Reich (Insider), Silva Santos (CEO), and Simon Sturge (Director). Learn More on MoonLake Immunotherapeutics' active insiders.

Are insiders buying or selling shares of MoonLake Immunotherapeutics?

In the last twelve months, insiders at the sold shares 6 times. They sold a total of 6,902,886 shares worth more than $52,850,547.07. The most recent insider tranaction occured on December, 9th when CEO Da Silva Jorge Santos sold 70,000 shares worth more than $1,014,300.00. Insiders at MoonLake Immunotherapeutics own 12.0% of the company. Learn More about insider trades at MoonLake Immunotherapeutics.

Information on this page was last updated on 12/9/2025.

Silva Jorge Santos Insider Trading History at MoonLake Immunotherapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/9/2025Sell70,000$14.49$1,014,300.002,878,577View SEC Filing Icon  
12/8/2025Sell130,000$15.08$1,960,400.002,948,577View SEC Filing Icon  
2/29/2024Sell4,740$55.89$264,918.602,982,814View SEC Filing Icon  
2/27/2024Sell62,810$55.00$3,454,550.003,043,619View SEC Filing Icon  
2/20/2024Sell20,000$57.44$1,148,800.003,107,554View SEC Filing Icon  
2/15/2024Sell20,000$60.18$1,203,600.003,147,554View SEC Filing Icon  
See Full Table

Silva Jorge Santos Buying and Selling Activity at MoonLake Immunotherapeutics

This chart shows Da Silva Jorge Santos's buying and selling at MoonLake Immunotherapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

MoonLake Immunotherapeutics Company Overview

MoonLake Immunotherapeutics logo
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland.
Read More

Today's Range

Now: $15.61
Low: $15.27
High: $15.82

50 Day Range

MA: $14.89
Low: $11.17
High: $18.49

2 Week Range

Now: $15.61
Low: $5.95
High: $62.75

Volume

1,012,848 shs

Average Volume

2,844,039 shs

Market Capitalization

$1.00 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21